From Bench to Bedside: Review of Gene and Cell-Based Therapies and the Slow Advancement into Phase 3 Clinical Trials, with a Focus on Aastrom’s Ixmyelocel-T

There is a large body of preclinical research demonstrating the efficacy of gene and cellular therapy for the potential treatment of severe (limb-threatening) peripheral arterial disease (PAD), including evidence for growth and transcription factors, monocytes, and mesenchymal stem cells. While prec...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartel, Ronnda L., Booth, Erin, Cramer, Caryn, Ledford, Kelly, Watling, Sharon, Zeigler, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Humana Press Inc 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680652/
https://www.ncbi.nlm.nih.gov/pubmed/23456574
http://dx.doi.org/10.1007/s12015-013-9431-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680652/
https://www.ncbi.nlm.nih.gov/pubmed/23456574
http://dx.doi.org/10.1007/s12015-013-9431-x

Ejemplares similares